KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 126 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $84,395,000 | -13.1% | 1,125,564 | -12.8% | 4.06% | -6.1% |
| Q2 2015 | $97,172,000 | +40.1% | 1,290,292 | -6.7% | 4.32% | +26.1% |
| Q1 2015 | $69,344,000 | +78.2% | 1,382,722 | +23.2% | 3.43% | +50.1% |
| Q4 2014 | $38,907,000 | +7.8% | 1,121,884 | +1.8% | 2.28% | -15.3% |
| Q3 2014 | $36,107,000 | -0.9% | 1,102,181 | +16.0% | 2.70% | -0.6% |
| Q2 2014 | $36,450,000 | -49.4% | 949,959 | -47.5% | 2.71% | -8.8% |
| Q1 2014 | $71,986,000 | +114.0% | 1,810,518 | +101.0% | 2.98% | -5.2% |
| Q4 2013 | $33,636,000 | +131.2% | 900,559 | +182.2% | 3.14% | +105.8% |
| Q3 2013 | $14,548,000 | +523.8% | 319,113 | +270.2% | 1.52% | +454.5% |
| Q2 2013 | $2,332,000 | – | 86,201 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |